These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21135811)

  • 1. Cardiac resynchronization therapy: current trends and future directions.
    Jacob S; Bharadwaj AS; Panaich SS; Mathew A; Afonso L
    Minerva Cardioangiol; 2010 Dec; 58(6):717-29. PubMed ID: 21135811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure patients selection for cardiac resynchronization therapy.
    Geng J; Wu B; Zheng L; Zhu J
    Eur J Intern Med; 2011 Feb; 22(1):32-8. PubMed ID: 21238890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure.
    Rosanio S; Schwarz ER; Ahmad M; Jammula P; Vitarelli A; Uretsky BF; Birnbaum Y; Ware DL; Atar S; Saeed M
    Am J Cardiol; 2005 Sep; 96(5):710-7. PubMed ID: 16125501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-pharmacological therapy of decompensated heart failure: cardiac resynchronization therapy].
    Storti C; Longobardi M; Buzzi MP; Negro MC; Pilun EB; Baldi A; Falcone C
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):123S-128S. PubMed ID: 19195320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator.
    Suzuki A; Shiga T; Nakai K; Futagawa K; Matsuyama Y; Shoda M; Kasanuki H; Hagiwara N
    J Electrocardiol; 2010; 43(6):706-12. PubMed ID: 20719332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
    Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
    Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy: state of the art 2013.
    Yu CM; Hayes DL
    Eur Heart J; 2013 May; 34(19):1396-403. PubMed ID: 23355652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy: a comprehensive review.
    Moskovitch J; Voskoboinik A
    Minerva Med; 2019 Apr; 110(2):121-138. PubMed ID: 30334442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy: expanding clinical indications and refining patient selection.
    Nery PB; Keren A; Birnie DH
    Curr Opin Cardiol; 2012 Mar; 27(2):137-42. PubMed ID: 22233979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS
    Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy update: evolving indications, expanding benefit?
    Butcher C; Mareev Y; Markides V; Mason M; Wong T; Cleland JG
    Curr Cardiol Rep; 2015 Oct; 17(10):90. PubMed ID: 26298308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.
    Taylor AJ; Elsik M; Broughton A; Cherayath J; Leet A; Wong C; Iles L; Butler M; Pfluger H
    Europace; 2010 May; 12(5):708-13. PubMed ID: 20190262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biventricular pacing: current trends and future strategies.
    Singh JP; Gras D
    Eur Heart J; 2012 Feb; 33(3):305-13. PubMed ID: 21951629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.